M. Dreyer

901 total citations
60 papers, 569 citations indexed

About

M. Dreyer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M. Dreyer has authored 60 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 23 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Molecular Biology. Recurrent topics in M. Dreyer's work include Diabetes Management and Research (18 papers), Diabetes and associated disorders (12 papers) and Diabetes Treatment and Management (12 papers). M. Dreyer is often cited by papers focused on Diabetes Management and Research (18 papers), Diabetes and associated disorders (12 papers) and Diabetes Treatment and Management (12 papers). M. Dreyer collaborates with scholars based in Germany, Denmark and Austria. M. Dreyer's co-authors include Hugo W. Rüdiger, Marjana Serdarevic-Pehar, Peter Lange, Anthony Barnett, J. Kühnau, H. W. R�diger, H. G. Dammann, Rudolf Prager, Ann Robinson and Graham Ellis and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

M. Dreyer

53 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Dreyer Germany 14 267 189 171 127 88 60 569
Vidya S. Farook United States 13 63 0.2× 198 1.0× 144 0.8× 122 1.0× 45 0.5× 29 515
Hilary M. Docherty United Kingdom 15 157 0.6× 288 1.5× 418 2.4× 202 1.6× 27 0.3× 22 607
Z. Nazará Mexico 16 41 0.2× 199 1.1× 108 0.6× 192 1.5× 28 0.3× 58 675
Rebecca Rodgers United States 12 49 0.2× 119 0.6× 534 3.1× 71 0.6× 44 0.5× 15 886
Abrahim I. Orabi United States 17 48 0.2× 158 0.8× 705 4.1× 81 0.6× 96 1.1× 29 878
Nadia Tinto Italy 15 80 0.3× 261 1.4× 250 1.5× 194 1.5× 28 0.3× 35 685
A. Schneider Germany 12 63 0.2× 166 0.9× 188 1.1× 40 0.3× 23 0.3× 23 518
Ken Ho Australia 6 304 1.1× 142 0.8× 53 0.3× 82 0.6× 20 0.2× 10 492
T Momoi Japan 11 227 0.9× 166 0.9× 74 0.4× 78 0.6× 28 0.3× 16 498
Nathalie Delalleau France 10 662 2.5× 313 1.7× 623 3.6× 231 1.8× 26 0.3× 19 901

Countries citing papers authored by M. Dreyer

Since Specialization
Citations

This map shows the geographic impact of M. Dreyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dreyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dreyer more than expected).

Fields of papers citing papers by M. Dreyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dreyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dreyer. The network helps show where M. Dreyer may publish in the future.

Co-authorship network of co-authors of M. Dreyer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dreyer. A scholar is included among the top collaborators of M. Dreyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dreyer. M. Dreyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreyer, M.. (2011). Periphere arterielle Verschlusskrankheit und Mikrozirkulationsstörungen bei Patienten mit Diabetes mellitus. Der Internist. 52(5). 533–538. 3 indexed citations
2.
Dreyer, M., et al.. (2008). Senkung der Plasma-Lipidkonzentration durch Lovastatin: Ergebnisse einer klinischen Prüfung bei Patienten mit primärer Hypercholesterinämie. DMW - Deutsche Medizinische Wochenschrift. 114(45). 1734–1739.
3.
Barnett, Anthony, et al.. (2007). Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes. International Journal of Clinical Practice. 61(10). 1614–1625. 28 indexed citations
4.
5.
Haupt, Axel, et al.. (2005). InDuo®, a Novel Combined Insulin Injection and Blood Glucose Monitoring Device - Effective and Save as Other Devices, and Patient Preference. Experimental and Clinical Endocrinology & Diabetes. 113(9). 541–544. 3 indexed citations
6.
Dreyer, M., Rudolf Prager, Ann Robinson, et al.. (2005). Efficacy and Safety of Insulin Glulisine in Patients with Type 1 Diabetes. Hormone and Metabolic Research. 37(11). 702–707. 57 indexed citations
7.
8.
9.
Knebel, Birgit, Jörg Kotzka, Gerhard Siemeister, et al.. (1997). Defects of Insulin and IGF-1 Action at Receptor and Postreceptor Level in a Patient with Type A Syndrome of Insulin Resistance. Biochemical and Biophysical Research Communications. 234(3). 626–630. 7 indexed citations
10.
Maldergem, Lionel Van, David Feldman, Roger Bouillon, et al.. (1996). Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Müllerian ducts in a Turkish boy born to consanguineous parents. American Journal of Medical Genetics. 64(3). 506–513. 21 indexed citations
11.
Cama, Alessandro, Maria De La Luz Sierra, Takashi Kadowaki, et al.. (1995). Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. Human Genetics. 95(2). 174–182. 20 indexed citations
12.
Müller‐Wieland, Dirk, Eric R. van der Vorm, Rüdiger Streicher, et al.. (1993). An in-frame insertion in exon 3 and a nonsense mutation in exon 2 of the insulin receptor gene associated with severe insulin resistance in a patient with Rabson-Mendenhall syndrome. Diabetologia. 36(11). 1168–1174. 17 indexed citations
13.
Dreyer, M., et al.. (1991). [Acidity profile in humans after multiple oral administration of hydrotalcite].. PubMed. 41(7). 738–41. 3 indexed citations
14.
Dreyer, M., et al.. (1989). [Single evening administration of a new antimuscarinic agent telenzepine in therapy of acute duodenal ulcer. Results of a randomized double-blind comparative study versus pirenzepine].. PubMed. 27(4). 203–6. 3 indexed citations
15.
Dammann, H. G., M. Dreyer, Peter Müller, & Bernd Simon. (1989). Rioprostil in the Acute and Long-Term Treatment of Peptic Ulcers: A Review. Scandinavian Journal of Gastroenterology. 24(sup164). 207–213. 3 indexed citations
16.
Dammann, H. G., M. Dreyer, Peter Müller, Bernd Simon, & P. Demol. (1989). A Single Evening Dose of Rioprostil, 600 μg, in the Treatment of Acute Duodenal Ulcers. Scandinavian Journal of Gastroenterology. 24(sup164). 215–218. 1 indexed citations
17.
Dreyer, M., et al.. (1989). A new familial syndrome with impaired function of three related peptide growth factors. Human Genetics. 83(3). 209–216. 6 indexed citations
18.
Dammann, H. G., M. Dreyer, R. Kangah, Peter Müller, & Bernd Simon. (1988). Optimale Reduktion der Magensäuresekretion bei peptischer Geschwürsbildung. Drugs. 35(Supplement 3). 106–113. 3 indexed citations
19.
Dreyer, M. & Hugo W. Rüdiger. (1988). Genetic defects of human receptor function. Trends in Pharmacological Sciences. 9(3). 98–102. 2 indexed citations
20.
Dammann, H. G., et al.. (1987). What are the current possibilities in treating peptic ulcer disease?. Alimentary Pharmacology & Therapeutics. 1(s1). 468S–492S. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vidya S. Farook Breakdown of academic impact, for papers by Hilary M. Docherty Breakdown of academic impact, for papers by Z. Nazará Breakdown of academic impact, for papers by Rebecca Rodgers Breakdown of academic impact, for papers by Abrahim I. Orabi Breakdown of academic impact, for papers by Nadia Tinto Breakdown of academic impact, for papers by A. Schneider Breakdown of academic impact, for papers by Ken Ho Breakdown of academic impact, for papers by T Momoi Breakdown of academic impact, for papers by Nathalie Delalleau
Rankless by CCL
2026